Repeated administration of CGP 46381, a γ-aminobutyric acidB antagonist, and ethosuximide suppresses seizure-associated cyclic adenosine 3′5′ monophosphate response element- and activator protein-1 DNA-binding activities in lethargic (lh/lh) mice